1. Home
  2. KOSS vs PSTV Comparison

KOSS vs PSTV Comparison

Compare KOSS & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Koss Corporation

KOSS

Koss Corporation

HOLD

Current Price

$4.13

Market Cap

39.3M

ML Signal

HOLD

Logo PLUS THERAPEUTICS Inc.

PSTV

PLUS THERAPEUTICS Inc.

HOLD

Current Price

$0.30

Market Cap

46.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KOSS
PSTV
Founded
1953
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.3M
46.4M
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
KOSS
PSTV
Price
$4.13
$0.30
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$6.75
AVG Volume (30 Days)
28.8K
6.6M
Earning Date
04-29-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
10.00
44.81
EPS
N/A
N/A
Revenue
$12,624,170.00
$5,824,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$45.87
P/E Ratio
N/A
N/A
Revenue Growth
2.93
18.54
52 Week Low
$4.00
$0.16
52 Week High
$8.59
$2.31

Technical Indicators

Market Signals
Indicator
KOSS
PSTV
Relative Strength Index (RSI) 41.99 49.43
Support Level N/A $0.26
Resistance Level $5.04 $0.32
Average True Range (ATR) 0.17 0.03
MACD -0.03 0.01
Stochastic Oscillator 18.75 57.68

Price Performance

Historical Comparison
KOSS
PSTV

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Share on Social Networks: